Hangzhou Gongze Pharmaceutical Technology Co., Ltd. is a specialized pharmaceutical technological unit. Now, we are mainly engaged in the research, manufacturing and trade of pharmaceutical intermediates, derivatives of chemical drugs, related fine chemicals, other rare chemical products and drugs; at the same time, we also provide the designing and synthetic service of compounds, and high-end technical supports. Up to now, we have successfully developed a series of APIs such as erlotinib, sunitinib, conivaptan hydrochloride and darunavir, etc.

At the early stage of our development, we are mainly focusing on the discovery and development of market-oriented Pharmaceutical intermediates and APIs. Taking market as guidance and R&D as supports, we are striving to get sustainable development and growth under the hard working of all staffs.